Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Filings indexed 1,608 across all filing types
Latest filing 2022-11-11 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
111年第3季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data in a tabular format showing changes in equity for a company over specific periods (the first three quarters of year 111 and 110 in the Taiwanese calendar, corresponding to 2022 and 2021). It includes line items such as common stock, capital surplus, legal surplus reserve, undistributed earnings, and total equity. The presence of comprehensive financial figures and period comparisons indicates this is a substantive financial report rather than a brief announcement or certification. The document length is 3802 characters, which is relatively short but contains actual financial data, not just a notice or link to a report. The content aligns with an Interim / Quarterly Report (IR) because it covers a period shorter than a full fiscal year and includes detailed financial statements. Therefore, the appropriate classification is IR (Interim / Quarterly Report).
2022-11-11 Chinese
111年第3季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the third quarter of the fiscal year 111 (which corresponds to 2022 in the Gregorian calendar). It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific amounts and accounting items. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is 2372 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement or certification. Therefore, the document is best classified as an Interim / Quarterly Report (IR).
2022-11-11 Chinese
111年第3季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement with detailed financial data for the third quarter of the year 111 (Taiwan calendar, corresponding to 2022) and comparative periods. It includes actual financial figures such as revenue, costs, expenses, net income, and earnings per share. The presence of substantive financial data for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 3879 characters, which is relatively short but contains detailed financial tables, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2022-11-11 Chinese
111年第3季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific asset, liability, and equity line items. The presence of actual financial figures and the nature of the content indicate this is a financial report rather than an announcement or certification. The data is for the third quarter of the year (111年第3季), which corresponds to an interim or quarterly period. The document length is 4316 characters, which is relatively short but contains substantive financial data. Given the detailed financial statements for a period shorter than a full fiscal year, this fits the definition of an Interim / Quarterly Report (IR).
2022-11-11 Chinese
111年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (中化生) reporting on the status of fund loans and endorsement guarantees for the current and previous month, including limits and cumulative amounts. It contains no detailed financial statements or analysis, but rather a summary of specific financial risk exposures. The document length is very short (602 characters), and it does not present a full financial report or management discussion. It is a regulatory disclosure of financial risk information, which fits best under the category of Regulatory Filings (RNS) as it does not meet criteria for Annual Report, Interim Report, or other detailed financial filings.
2022-11-10 Chinese
111年10月營業收入
Interim / Quarterly Report Classification · 90% confidence The document is a summarized revenue report for a company named 中化生 for the month of October in 民國111年 (2022). It contains monthly and cumulative net operating revenue figures, percentage changes compared to the previous year, and explanations for revenue changes. The document is short (793 characters) and primarily provides financial data for a specific period without detailed financial statements or comprehensive analysis. It does not appear to be a full annual or interim report, nor is it an announcement or presentation. Given the nature of the data and the length, it fits best as an Interim / Quarterly Report (IR), as it provides substantive financial data for a period shorter than a full fiscal year.
2022-11-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.